Mylan Says Unharmed EpiPen Loyalists Undercut Class Cert.
By Christopher Cole · December 21, 2021, 6:45 PM EST
The seller of the EpiPen has urged a Kansas federal judge to reconsider keeping a class of buyers intact in a massive antitrust suit accusing the company of unlawfully blocking generic rivals,...
To view the full article, register now.